Home › Crohn's Disease › New Hampshire
Crohn's Disease clinical trials in New Hampshire
3 studies for Crohn's Disease are looking for participants at sites in New Hampshire.
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Dartmouth Hitchcock, Lebanon
Recruiting
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT05230173Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 27, 2026 · NCT06456593From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.